HealthEquity Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Financial Results - HealthEquity, Inc. is set to release its fourth-quarter financial results on March 18, with expected earnings of 72 cents per share, an increase from 63 cents per share in the previous year [1] - The company projects quarterly revenue of $305.82 million, compared to $262.39 million a year earlier [1] Stock Performance - HealthEquity shares increased by 3.4%, closing at $100.72 [2] Analyst Ratings - Barrington Research analyst Alexander Paris maintained an Outperform rating with a price target of $112 [4] - Raymond James analyst C. Gregory Peters raised the price target from $105 to $120 while maintaining an Outperform rating [4] - Mizuho analyst Steven Valiquette initiated coverage with an Outperform rating and a price target of $126 [4] - B of A Securities analyst Allen Lutz raised the price target from $100 to $120 while maintaining a Buy rating [4] - Deutsche Bank analyst George Hill increased the price target from $102 to $103 while maintaining a Buy rating [4]